HEPCINAT 400MG is a cancer medication that interferes with the growth and spread of cancer cells in the body.
HEPCINAT 400MG (Sofosbuvir) film coated tablets each contain 400mg of the main ingredient. The dosage schedule must be individualized by the physician in charge of treatment, and will vary according to the viral genotype that is being treated. Adult patients will usually be directed by their physician to take 1 tablet per day, and it can be administered alongside a meal or else without food.Those suffering from GT1 or GT4 (genotype 1 or 4) may be ordered by the physician to take it alongside ribavirin and peginterferon alfa, with treatment lasting for a period of 12 weeks. In contrast to this, GT2 (genotype 2) is usually treated for 12 weeks, and it is taken alongside ribavirin. GT3 (genotype 3) requires 24 weeks of treatment in combination with ribavirin. Patients must only take it according to the instructions provided to them by the physician in charge of treatment.
USES OF DACLATASVIR
Daclatasvir is used in the treatment of chronic hepatitis C virus (HCV) infection.
USES OF SOFOSBUVIR
Sofosbuvir is used in the treatment of chronic hepatitis C virus (HCV) infection.
Only logged in customers who have purchased this product may leave a review.